PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Previously Untreated Multiple Myeloma (ELO 1 Substudy)
Public ClinicalTrials.gov record NCT01891643. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Subjects With Previously Untreated Multiple Myeloma
Study identification
- NCT ID
- NCT01891643
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 23 participants
Conditions and interventions
Interventions
- Lenalidomide Drug
- Dexamethasone Drug
- Elotuzumab Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 29, 2013
- Primary completion
- Jun 24, 2020
- Completion
- Jun 24, 2020
- Last update posted
- Jun 30, 2021
2013 – 2020
United States locations
- U.S. sites
- 9
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pacific Hematology Oncology Associates | San Francisco | California | 94115 | — |
| Memorial Cancer Institute | Hollywood | Florida | 33021 | — |
| Illinois Cancercare, Pc | Peoria | Illinois | 61615 | — |
| Franciscan St. Francis Health | Indianapolis | Indiana | 46237 | — |
| Crescent City Research Consortium, LLC | Marrero | Louisiana | 70072 | — |
| Ohio State University Medical Center | Columbus | Ohio | 43210 | — |
| Medical University Of South Carolina Hollings Cancer Center | Charleston | South Carolina | 29425 | — |
| Baptist Cancer Center | Memphis | Tennessee | 38120 | — |
| Northern Utah Associates | Ogden | Utah | 84405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01891643, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 30, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01891643 live on ClinicalTrials.gov.